These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34012950)

  • 21. Shifts of SARS-CoV-2 exposure settings in the transmission clusters of 2 epidemic waves in Hong Kong.
    Kwan TH; Wong NS; Yeoh EK; Lee SS
    Int J Environ Health Res; 2023 Sep; 33(9):911-923. PubMed ID: 35437073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the impact of travel restrictions on COVID-19 cases in Hong Kong in early 2020.
    Kwok WC; Wong CK; Ma TF; Ho KW; Fan LW; Chan KF; Chan SS; Tam TC; Ho PL
    BMC Public Health; 2021 Oct; 21(1):1878. PubMed ID: 34663279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic.
    Guo Z; Zhao S; Lee SS; Hung CT; Wong NS; Chow TY; Yam CHK; Wang MH; Wang J; Chong KC; Yeoh EK
    Epidemics; 2023 Mar; 42():100670. PubMed ID: 36709540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore.
    Zhu S; Tao J; Gao H; He D
    BMC Res Notes; 2020 Jul; 13(1):336. PubMed ID: 32660556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pandemic fatigue and attenuated impact of avoidance behaviours against COVID-19 transmission in Hong Kong by cross-sectional telephone surveys.
    Gao H; Du Z; Tsang TK; Xiao J; Shan S; Liao Q; Wu P; Leung GM; Cowling BJ
    BMJ Open; 2021 Dec; 11(12):e055909. PubMed ID: 34930744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of early phase local-to-local transmissibility and importation hazard of Coronavirus Disease 2019 (COVID-19) epidemic under assorted containment measures in Hong Kong.
    Kwok KO; Wan In W; Huang Y; Wong A; Tang A; Wong SYS
    Travel Med Infect Dis; 2022; 45():102226. PubMed ID: 34861416
    [No Abstract]   [Full Text] [Related]  

  • 27. Universal Community Nucleic Acid Testing for Coronavirus Disease 2019 (COVID-19) in Hong Kong Reveals Insights Into Transmission Dynamics: A Cross-Sectional and Modeling Study.
    Yang B; Tsang TK; Gao H; Lau EHY; Lin Y; Ho F; Xiao J; Wong JY; Adam DC; Liao Q; Wu P; Cowling BJ; Leung GM
    Clin Infect Dis; 2022 Aug; 75(1):e216-e223. PubMed ID: 34718464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Spatiotemporal Solution to Control COVID-19 Transmission at the Community Scale for Returning to Normalcy: COVID-19 Symptom Onset Risk Spatiotemporal Analysis.
    Tong C; Shi W; Zhang A; Shi Z
    JMIR Public Health Surveill; 2023 Jan; 9():e36538. PubMed ID: 36508488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Tale of 3 Asian Cities: How is Primary Care Responding to COVID-19 in Hong Kong, Singapore, and Beijing.
    Wong SYS; Tan DHY; Zhang Y; Ramiah A; Zeng X; Hui E; Young DYL
    Ann Fam Med; 2021; 19(1):48-54. PubMed ID: 33431392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong.
    Chua GT; Wong JSC; Lam I; Ho PPK; Chan WH; Yau FYS; Rosa Duque JS; Ho ACC; Siu KK; Cheung TWY; Lam DSY; Chan VCM; Lee KP; Tsui KW; Wong TW; Yau MM; Yau TY; Chan KCC; Yu MWL; Chow CK; Chiu WK; Chan KC; Wong WHS; Ho MHK; Tso WWY; Tung KTS; Wong CS; Kwok J; Leung WH; Yam JC; Wong ICK; Tam PKH; Chan GCF; Chow CB; To KKW; Lau YL; Yuen KY; Ip P; Kwan MYW
    JAMA Netw Open; 2021 May; 4(5):e218824. PubMed ID: 33938934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 in Hong Kong - Public health, food safety, and animal vectors perspectives.
    Hon KL; Leung KKY; Tang JW; Leung AKC; Li Y
    J Virol Methods; 2021 Apr; 290():114036. PubMed ID: 33285191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.
    Kwok KO; Li KK; Chan HHH; Yi YY; Tang A; Wei WI; Wong SYS
    Emerg Infect Dis; 2020 Jul; 26(7):1575-1579. PubMed ID: 32298227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and Long-Term Care Policy for Older People in Hong Kong.
    Lum T; Shi C; Wong G; Wong K
    J Aging Soc Policy; 2020; 32(4-5):373-379. PubMed ID: 32476597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore.
    Kwok KO; Chan HHH; Huang Y; Hui DSC; Tambyah PA; Wei WI; Chau PYK; Wong SYS; Tang JWT
    J Hosp Infect; 2020 Aug; 105(4):682-685. PubMed ID: 32446721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong.
    Gu H; Chu DKW; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Xie R; Cheng SSM; Cowling BJ; Tsang DNC; Peiris M; Dhanasekaran V; Poon LLM
    Emerg Infect Dis; 2021 Oct; 27(10):2666-2668. PubMed ID: 34545799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong?
    Siu GK; Lee LK; Leung KS; Leung JS; Ng TT; Chan CT; Tam KK; Lao HY; Wu AK; Yau MC; Lai YW; Fung KS; Chau SK; Wong BK; To WK; Luk K; Ho AY; Que TL; Yip KT; Yam WC; Shum DH; Yip SP
    Emerg Microbes Infect; 2020 Dec; 9(1):2497-2500. PubMed ID: 33206025
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong.
    Chong KC; Chan PK; Hung CT; Wong CK; Xiong X; Wei Y; Zhao S; Guo Z; Wang H; Yam CH; Chow TY; Li C; Jiang X; Leung SY; Kwok KL; Yeoh EK; Li K
    J Glob Health; 2023 Apr; 13():06017. PubMed ID: 37114968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
    Chan PKS; Lui G; Hachim A; Ko RLW; Boon SS; Li T; Kavian N; Luk F; Chen Z; Yau EM; Chan KH; Tsang CH; Cheng SMS; Chu DKW; Perera RAPM; Ho WCS; Yeung ACM; Chow C; Poon LLM; Valkenburg SA; Hui DSC; Peiris M
    Emerg Infect Dis; 2020 Dec; 26(12):3076-3078. PubMed ID: 33089772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.
    Cheng VCC; Wong SC; Chen JHK; Yip CCY; Chuang VWM; Tsang OTY; Sridhar S; Chan JFW; Ho PL; Yuen KY
    Infect Control Hosp Epidemiol; 2020 May; 41(5):493-498. PubMed ID: 32131908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiological characteristics of three local epidemics of COVID-19 in Guangzhou].
    Zhao WH; Ma Y; Wang H; Li K; Dong H; Liu WH; Liu YY; Jiang SQ; Luo L; Yang ZC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2088-2095. PubMed ID: 34954969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.